Description
AZD4635 is an investigational drug currently being studied in clinical trials for various advanced solid cancers, including colorectal cancer. It is being evaluated in Phase 1 trials to determine its safety, how it's processed by the body (pharmacokinetics), and if it shows early signs of effectiveness (preliminary anti-tumor activity). These trials involve different ways of giving the drug, including capsules and a nanoparticle suspension. AZD4635 is being tested both alone (monotherapy) and in combination with other cancer treatments like durvalumab, oleclumab, and docetaxel. The trials are designed to find the best dose and understand how patients respond to the drug.
Mechanism of Action
AZD4635 is being investigated as a potential treatment for advanced cancers. The specific way it works (its mechanism of action) is still being studied in clinical trials. It is being tested alone and in combination with other therapies to see how it affects cancer cells and the body's response.
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.